vs

Side-by-side financial comparison of HARROW, INC. (HROW) and PagerDuty, Inc. (PD). Click either name above to swap in a different company.

PagerDuty, Inc. is the larger business by last-quarter revenue ($124.5M vs $89.1M, roughly 1.4× HARROW, INC.). PagerDuty, Inc. runs the higher net margin — 129.7% vs 7.4%, a 122.3% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 4.7%). PagerDuty, Inc. produced more free cash flow last quarter ($24.1M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 5.9%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.

HROW vs PD — Head-to-Head

Bigger by revenue
PD
PD
1.4× larger
PD
$124.5M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+28.6% gap
HROW
33.3%
4.7%
PD
Higher net margin
PD
PD
122.3% more per $
PD
129.7%
7.4%
HROW
More free cash flow
PD
PD
$16.0M more FCF
PD
$24.1M
$8.1M
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
5.9%
PD

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HROW
HROW
PD
PD
Revenue
$89.1M
$124.5M
Net Profit
$6.6M
$161.6M
Gross Margin
79.3%
85.3%
Operating Margin
17.5%
6.5%
Net Margin
7.4%
129.7%
Revenue YoY
33.3%
4.7%
Net Profit YoY
-2.2%
2827.7%
EPS (diluted)
$0.20
$1.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
PD
PD
Q4 25
$89.1M
$124.5M
Q3 25
$71.6M
$123.4M
Q2 25
$63.7M
$119.8M
Q1 25
$47.8M
$121.4M
Q4 24
$66.8M
$118.9M
Q3 24
$49.3M
$115.9M
Q2 24
$48.9M
$111.2M
Q1 24
$34.6M
$111.1M
Net Profit
HROW
HROW
PD
PD
Q4 25
$6.6M
$161.6M
Q3 25
$1.0M
$9.6M
Q2 25
$5.0M
$-7.2M
Q1 25
$-17.8M
$-8.8M
Q4 24
$6.8M
$-5.9M
Q3 24
$-4.2M
$-10.9M
Q2 24
$-6.5M
$-17.1M
Q1 24
$-13.6M
$-28.2M
Gross Margin
HROW
HROW
PD
PD
Q4 25
79.3%
85.3%
Q3 25
75.3%
84.6%
Q2 25
74.5%
84.0%
Q1 25
67.5%
83.6%
Q4 24
78.8%
83.0%
Q3 24
75.6%
82.7%
Q2 24
74.4%
82.6%
Q1 24
69.5%
81.7%
Operating Margin
HROW
HROW
PD
PD
Q4 25
17.5%
6.5%
Q3 25
20.6%
2.9%
Q2 25
17.9%
-8.6%
Q1 25
-23.5%
-9.6%
Q4 24
19.3%
-8.7%
Q3 24
2.7%
-13.8%
Q2 24
3.1%
-19.5%
Q1 24
-20.0%
-30.1%
Net Margin
HROW
HROW
PD
PD
Q4 25
7.4%
129.7%
Q3 25
1.4%
7.8%
Q2 25
7.8%
-6.0%
Q1 25
-37.2%
-7.2%
Q4 24
10.1%
-5.0%
Q3 24
-8.6%
-9.4%
Q2 24
-13.2%
-15.4%
Q1 24
-39.2%
-25.3%
EPS (diluted)
HROW
HROW
PD
PD
Q4 25
$0.20
$1.69
Q3 25
$0.03
$0.10
Q2 25
$0.13
$-0.07
Q1 25
$-0.50
$-0.12
Q4 24
$0.19
$-0.07
Q3 24
$-0.12
$-0.14
Q2 24
$-0.18
$-0.26
Q1 24
$-0.38
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
PD
PD
Cash + ST InvestmentsLiquidity on hand
$72.9M
$547.8M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$320.5M
Total Assets
$399.5M
$1.0B
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
PD
PD
Q4 25
$72.9M
$547.8M
Q3 25
$74.3M
$567.9M
Q2 25
$53.0M
$597.1M
Q1 25
$66.7M
$570.8M
Q4 24
$47.2M
$542.2M
Q3 24
$72.6M
$599.3M
Q2 24
$71.0M
$592.8M
Q1 24
$76.0M
$571.2M
Total Debt
HROW
HROW
PD
PD
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
$484.5M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
$489.5M
Stockholders' Equity
HROW
HROW
PD
PD
Q4 25
$52.4M
$320.5M
Q3 25
$47.0M
$180.7M
Q2 25
$49.7M
$145.7M
Q1 25
$56.5M
$129.8M
Q4 24
$69.7M
$111.6M
Q3 24
$58.0M
$164.7M
Q2 24
$58.5M
$174.0M
Q1 24
$60.6M
$171.6M
Total Assets
HROW
HROW
PD
PD
Q4 25
$399.5M
$1.0B
Q3 25
$363.1M
$891.5M
Q2 25
$345.0M
$926.8M
Q1 25
$364.2M
$927.3M
Q4 24
$389.0M
$866.8M
Q3 24
$351.5M
$916.0M
Q2 24
$306.6M
$924.0M
Q1 24
$295.5M
$925.3M
Debt / Equity
HROW
HROW
PD
PD
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
3.73×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×
2.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
PD
PD
Operating Cash FlowLast quarter
$8.4M
$24.8M
Free Cash FlowOCF − Capex
$8.1M
$24.1M
FCF MarginFCF / Revenue
9.1%
19.3%
Capex IntensityCapex / Revenue
0.4%
0.6%
Cash ConversionOCF / Net Profit
1.27×
0.15×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$117.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
PD
PD
Q4 25
$8.4M
$24.8M
Q3 25
$16.6M
$34.0M
Q2 25
$-803.0K
$30.7M
Q1 25
$19.7M
$31.4M
Q4 24
$-17.8M
$22.1M
Q3 24
$3.0M
$35.8M
Q2 24
$-2.7M
$28.6M
Q1 24
$-4.6M
$22.2M
Free Cash Flow
HROW
HROW
PD
PD
Q4 25
$8.1M
$24.1M
Q3 25
$16.4M
$33.1M
Q2 25
$-969.0K
$30.2M
Q1 25
$19.5M
$30.3M
Q4 24
$-18.3M
$21.5M
Q3 24
$2.3M
$35.1M
Q2 24
$-3.1M
$28.2M
Q1 24
$-4.7M
$21.2M
FCF Margin
HROW
HROW
PD
PD
Q4 25
9.1%
19.3%
Q3 25
22.9%
26.8%
Q2 25
-1.5%
25.2%
Q1 25
40.8%
24.9%
Q4 24
-27.4%
18.1%
Q3 24
4.8%
30.3%
Q2 24
-6.3%
25.4%
Q1 24
-13.6%
19.1%
Capex Intensity
HROW
HROW
PD
PD
Q4 25
0.4%
0.6%
Q3 25
0.3%
0.7%
Q2 25
0.3%
0.4%
Q1 25
0.4%
0.9%
Q4 24
0.8%
0.5%
Q3 24
1.2%
0.5%
Q2 24
0.7%
0.4%
Q1 24
0.3%
0.9%
Cash Conversion
HROW
HROW
PD
PD
Q4 25
1.27×
0.15×
Q3 25
16.26×
3.55×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

PD
PD

US$88.8M71%
Non Us$35.7M29%

Related Comparisons